Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Spectral Medical Inc T.EDT

Alternate Symbol(s):  EDTXF

Spectral Medical Inc. is a Canada-based late-stage theragnostic company advancing therapeutic options for sepsis and septic shock. The Company develops and commercializes a treatment for septic shock utilizing its Endotoxin Activity Assay (EAA) diagnostic and the Toraymyxin therapeutic (PMX). PMX is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the bloodstream and is guided by the Company’s EAA. PMX is approved for therapeutic use in Japan and Europe and has been used safely and effectively on more than 340,000 patients to date. It has pioneered the development of biochemical markers for the clinical syndrome known as septic shock. It is continuing its legacy business of manufacturing and selling certain proprietary reagents. It develops, produces and markets recombinant proteins, antibodies and calibrators. These materials are sold for use in research and development, as well as in products manufactured by other diagnostic companies.


TSX:EDT - Post by User

Post by TechOneon May 31, 2023 2:19am
322 Views
Post# 35471689

Light at the end of the Tunnel

Light at the end of the Tunnel So as the sites are added and pace of patience enrolement is picking up, I expect sooner or later 1 patient per site per month will happen..   So 2-4 months for some meaningful numbers is what I expect. as I have mentioned before.. 

I want to see a move to Nasdaq or NY but not at these levels because the management has last 3-4 years, every year around AGM time asked for share holder's approval for a reverse split of 1 for 10 or even as high as 1 for 20..  Needless to say, I don't like 1 for 20 reverse and certainly DO NOT want these guys to just list without serious numbers and Bexter's buy in at 90 patient interim results..  If you don't have very solid results to back it, reverse split is ALWAYS a losing proposition.. Do it right and if you can't, don't do it until share price is around at least couple of bucks..

Any ways, for now retail share holders IMHO have no clout for anything as long as they have Toray and another Instituion with big numbers of shares supporting the management..  I must say, CEO has been paid too handsomely for the results he has delivered...  Not really happy about it but for now holding my nose and keeping the shares.. 

FWIW 
<< Previous
Bullboard Posts
Next >>